TY - JOUR
T1 - The ubiquitin-like protein FAT10 mediates NF-κB activation
AU - Gong, Pengfei
AU - Canaan, Allon
AU - Wang, Bin
AU - Leventhal, Jeremy
AU - Snyder, Alexandra
AU - Nair, Viji
AU - Cohen, Clemens D.
AU - Kretzler, Matthias
AU - D'Agati, Vivette
AU - Weissman, Sherman
AU - Ross, Michael J.
PY - 2010/2
Y1 - 2010/2
N2 - NF-κB is a central mediator of innate immunity and contributes to the pathogenesis of several renal diseases. FAT10 is a TNF-α-inducible ubiquitin-like protein with a putative role in immune response, but whether FAT10 participates in TNF-α-induced NF-κB activation is unknown. Here, using renal tubular epithelial cells (RTECs) derived from FAT10 -/- and FAT10-/- mice, we observed that FAT10 deficiency abrogated TNF-α-induced NF-κB activation and reduced the induction of NF-κB-regulated genes. Despite normal IkBα degradation and polyubiquitination, FAT10 deficiency impaired TNF-α-induced IkBα degradation and nuclear translocation of p65 in RTECs, suggesting defective proteasomal degradation of polyubiquitinated IkBα. In addition, FAT10 deficiency reduced the expression of the proteasomal subunit low molecular mass polypeptide 2 (LMP2). Transduction of FAT10-/- RTECs with FAT10 restored LMP2 expression, TNF-α-induced IkBα degradation, p65 nuclear translocation, and NF-κB activation. Furthermore, LMP2 transfection restored IkBα degradation in FAT10-/- RTECs. In humans, common types of chronic kidney disease associated with tubulointerstitial upregulation of FAT10. These data suggest that FAT10 mediates NF-κB activation and may promote tubulointerstitial inflammation in chronic kidney diseases.
AB - NF-κB is a central mediator of innate immunity and contributes to the pathogenesis of several renal diseases. FAT10 is a TNF-α-inducible ubiquitin-like protein with a putative role in immune response, but whether FAT10 participates in TNF-α-induced NF-κB activation is unknown. Here, using renal tubular epithelial cells (RTECs) derived from FAT10 -/- and FAT10-/- mice, we observed that FAT10 deficiency abrogated TNF-α-induced NF-κB activation and reduced the induction of NF-κB-regulated genes. Despite normal IkBα degradation and polyubiquitination, FAT10 deficiency impaired TNF-α-induced IkBα degradation and nuclear translocation of p65 in RTECs, suggesting defective proteasomal degradation of polyubiquitinated IkBα. In addition, FAT10 deficiency reduced the expression of the proteasomal subunit low molecular mass polypeptide 2 (LMP2). Transduction of FAT10-/- RTECs with FAT10 restored LMP2 expression, TNF-α-induced IkBα degradation, p65 nuclear translocation, and NF-κB activation. Furthermore, LMP2 transfection restored IkBα degradation in FAT10-/- RTECs. In humans, common types of chronic kidney disease associated with tubulointerstitial upregulation of FAT10. These data suggest that FAT10 mediates NF-κB activation and may promote tubulointerstitial inflammation in chronic kidney diseases.
UR - http://www.scopus.com/inward/record.url?scp=77949362894&partnerID=8YFLogxK
U2 - 10.1681/ASN.2009050479
DO - 10.1681/ASN.2009050479
M3 - Article
C2 - 19959714
AN - SCOPUS:77949362894
SN - 1046-6673
VL - 21
SP - 316
EP - 326
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
IS - 2
ER -